Evidence map›Paper›PMID 18953024›Full record

ArticleNucleic acids research2009

HMDB: a knowledgebase for the human metabolome.

David S Wishart, Craig Knox, An Chi Guo, Roman Eisner, Nelson Young, Bijaya Gautam, David D Hau, Nick Psychogios, Edison Dong, Souhaila Bouatra and 28 more

Abstract read
In one paragraph

Article in Nucleic acids research, 2009. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 809 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
809citing papers in PubMed, 2 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

809 citing papers in PubMed, 2 syntheses or guidelines pooled it.

  1. Pooled it
  2. Metabolomic biomarkers of low BMD: a systematic review.Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA · 2021
    Pooled it
  3. Trial
  4. Review
  5. Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. The NMR Exchange Format (NEF): Specification and Applications.bioRxiv : the preprint server for biology · 2026
    Article
  15. Article
  16. Cholecalciferol (vitamin D3) is an agonist of the Alzheimer's disease-associated immune receptor TREM2.Neurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics · 2026
    Article
  17. Review
  18. Article
  19. Live Metabolomics with NMR.Analytical chemistry · 2026
    Review
  20. Article

749 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

38 authors.

David S WishartDepartment of Computing Science, Department of Biological Sciences, University of Alberta, Edmonton, AB, Canada T6G 2E8. david.wishart@ualberta.ca
Craig Knox
An Chi Guo
Roman Eisner
Nelson Young
Bijaya Gautam
David D Hau
Nick Psychogios
Edison Dong
Souhaila Bouatra
Rupasri Mandal
Igor Sinelnikov
Jianguo Xia
Leslie Jia
Joseph A Cruz
Emilia Lim
Constance A Sobsey
Savita Shrivastava
Paul Huang
Philip Liu
Lydia Fang
Jun Peng
Ryan Fradette
Dean Cheng
Dan Tzur
Melisa Clements
Avalyn Lewis
Andrea De Souza
Azaret Zuniga
Margot Dawe
Yeping Xiong
Derrick Clive
Russ Greiner
Alsu Nazyrova
Rustem Shaykhutdinov
Liang Li
Hans J Vogel
Ian Forsythe

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The Human Metabolome Database (HMDB, http://www.hmdb.ca) is a richly annotated resource that is designed to address the broad needs of biochemists, clinical chemists, physicians, medical geneticists, nutritionists and members of the metabolomics community. Since its first release in 2007, the HMDB has been used to facilitate the research for nearly 100 published studies in metabolomics, clinical biochemistry and systems biology. The most recent release of HMDB (version 2.0) has been significantly expanded and enhanced over the previous release (version 1.0). In particular, the number of fully annotated metabolite entries has grown from 2180 to more than 6800 (a 300% increase), while the number of metabolites with biofluid or tissue concentration data has grown by a factor of five (from 883 to 4413). Similarly, the number of purified compounds with reference to NMR, LC-MS and GC-MS spectra has more than doubled (from 380 to more than 790 compounds). In addition to this significant expansion in database size, many new database searching tools and new data content has been added or enhanced. These include better algorithms for spectral searching and matching, more powerful chemical substructure searches, faster text searching software, as well as dedicated pathway searching tools and customized, clickable metabolic maps. Changes to the user-interface have also been implemented to accommodate future expansion and to make database navigation much easier. These improvements should make the HMDB much more useful to a much wider community of users.

Indexed as

Databases, FactualMetabolomeHumansMagnetic Resonance SpectroscopyMass SpectrometryMetabolic Networks and PathwaysUser-Computer Interface

Identifiers

PMID18953024
PMCPMC2686599

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.